RecruitingNCT03495024
Varenicline study for smoking cessation in schizophrenia
About this title
Read the official source — NCT03495024Medication studyAges 18–75United States
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
- Listed locations
- PhiladelphiaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 1, 2019
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 10
- Sponsor
- Corporal Michael J. Crescenz VA Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT03495024
- Official title
Show the full official title
Effect of Varenicline on Smoking Cessation in Patients With Schizophrenia: Evaluation of Antipsychotic Drug-Induced Neurological Symptoms as Correlates of Response
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Corporal Michael J. Crescenz VA Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Varenicline.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
